Tiga TX develops an IgA therapeutic monoclonal antibody platform to activate neutrophils for the treatment of solid tumors.

Biotechnology

Health Care

Therapeutics

Tiga TX

Anne Altmeyer

Cassandra Choe-Juliak

Howard Stern

Stefan Pflanz

Dan McHugh

Edward Van Wezel

Maarten de Jong

Aaron Nelson

Jeanette Leusen

Sonia Gulati

The Directors Team at Tiga TX is responsible for setting the strategic vision, overseeing the development of the IgA therapeutic monoclonal antibody platform, and ensuring alignment across all departments. This team directs high-level decision-making processes and guides the company toward achieving its mission in the treatment of solid tumors.

Directors Team

The Leadership Team at Tiga TX spearheads strategic initiatives and oversees the development of the company's IgA therapeutic monoclonal antibody platform. Comprised of key executives like the CSO, VP of Immuno-oncology, CEO, CMO, and Scientific Founder, the team ensures cohesive direction in research, clinical development, and business operations to advance treatments for solid tumors.

Leadership Team

Tiga TX

Org chart

Board & advisors

Teams

Directors Team

Leadership Team

Offices

Tiga TX

Org chart

Board & advisors

Teams

Directors Team

Leadership Team

Offices

Related companies